Skip to content

Full Automaticity and Remote Follow-up

Identification of Implantable Cardioverter Defibrillator Patients With Remote Follow up That Requires an Onsite Visit

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01526629
Enrollment
354
Registered
2012-02-06
Start date
2011-05-31
Completion date
2015-03-31
Last updated
2025-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tachyarrhythmia

Keywords

ICD, Remote follow-up

Brief summary

With the expansion of Sudden Cardiac Death (SCD) primary prevention indications, the number of Implantable Cardioverter Defibrillators (ICD) implants has increased significantly in the recent years. This has resulted in an increase of the number of follow-up (FU) to be performed and a growing workload for centers. Remote FU system such as the Medtronic Carelink system allows to check remotely the proper functioning of self evaluating devices and give informations of some clinical events. The objective of this study is to define which patients with a remote follow-up need additional onsite visit and to assess to which extent remote FU can be an alternative to onsite visit.

Interventions

None listed

Sponsors

Medtronic
CollaboratorINDUSTRY
Medtronic Cardiac Rhythm and Heart Failure
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient older than 18, * Patient implanted with a fully automatic ICD and remotely followed-up, * Patient geographically stable and able to attend FU at investigative site * Patient who signed a data release authorization form,

Exclusion criteria

* Patient whose mental or physical capacity impedes to give an informed data release authorization, * Patient already enrolled in a clinical study whose procedures may interfere with the results of the present study, * Patients in New York Heart Association (NYHA) class IV

Design outcomes

Primary

MeasureTime frameDescription
Remote Follow-up as an Alternative to Onsite Visit13 monthsEvaluate the percentage of patients who had a successful remote follow up, as an alternative to onsite visit for patients implanted with a fully automatic ICD

Countries

France

Participant flow

Participants by arm

ArmCount
ICD Patients With Remote Follow-up
Patients implanted with a fully automatic ICD and remotely followed-up.
354
Total354

Baseline characteristics

CharacteristicICD Patients With Remote Follow-up
Age, Customized
Men
65 years
Age, Customized
Women
56 years
Region of Enrollment
France
354 participants
Sex: Female, Male
Female
66 Participants
Sex: Female, Male
Male
288 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 354
serious
Total, serious adverse events
75 / 354

Outcome results

Primary

Remote Follow-up as an Alternative to Onsite Visit

Evaluate the percentage of patients who had a successful remote follow up, as an alternative to onsite visit for patients implanted with a fully automatic ICD

Time frame: 13 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ICD Patients With Remote Follow-upRemote Follow-up as an Alternative to Onsite Visit203 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026